SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Trading Update

12 Aug 2013 07:00

RNS Number : 4221L
PROACTIS Holdings PLC
12 August 2013
 



Date:

12 August 2013

On behalf of: 

PROACTIS Holdings PLC ("Proactis" the "Company" or "the Group")

Embargoed until:

0700hrs

 

 

PROACTIS Holdings PLC

Trading Update

 

PROACTIS Holdings PLC, a global Spend Control and eProcurement solution provider, is pleased to update the market on trading for the financial year ended 31 July 2013. The Group confirms that results are expected to be in line with current market expectations, with revenues of £8.0m, adjusted EBITDA of £1.3m and adjusted profit before tax of £0.6m.

 

The Group's cash position at the end of July was approximately £2.4m and the Group remains debt free.

 

The Group starts the new financial year with an order book in excess of £6.0m and a healthy pipeline of new deal opportunities. The Board is confident of the continuing prospects for growth for the coming year.

 

The Group's results for the year ended 31 July 2013 will be announced on or around Wednesday 2 October 2013.

 

Rod Jones, Chief Executive commented:

 

"The past year has been significant for PROACTIS. With our shift toward a blended SaaS/Cloud and perpetual licensed business model just completing its third full year, we are seeing the realisation of the reliable profits that we had planned for. Our commitment to building an enhanced product remains and we are continuing to receive plaudits from the market on its breadth and depth. Our pipeline of prospects remains solid and we are confident that we will extend our already strong position within the Spend and eProcurement market place".

 

 

End

 

For further information, please contact:

 

PROACTIS Holdings PLC

Rod Jones, Chief Executive Officer

Tim Sykes, Chief Financial Office

 

Via Redleaf Polhill

 

Redleaf Polhill

Rebecca Sanders-Hewett

Jenny Bahr

0207 382 4730

finnCap Limited

Charlotte Stranner

0207 220 0500

 

 

 

 

 

 

 

 

Notes to Editors:

 

PROACTIS is a leading provider of Spend Control and eProcurement solutions. Hundreds of organisations around the world use PROACTIS software and services to streamline and automate processes and obtain best value and control in procurement.

 

Source-to-contract solutions: help organisations to automate the full buying cycle from improving the way they find, evaluate and engage suppliers to increasing "on contract" spending and enabling more effective collaboration with their trading network.

 

Purchase-to-Pay solutions: enable organisations to streamline the purchase to pay process, eliminate labour-intensive manual registration of invoices, speed up invoice matching and approvals and gain control of the "after-the-event" purchase claims.

 

Widely used in mid-to-large sized organisations across private, public and not-for-profit sectors, PROACTIS is routinely integrated with ERP and financial systems. PROACTIS also offers a range of cloud-based delivery options, including Software-as-a-Service ("SaaS") and dedicated-hosted application delivery, and flexible licensing models.

 

PROACTIS was founded in 1996 and has been listed on the London Stock Exchange since 2006 (AIM: phd). Headquartered in the UK with direct operations in Europe, North America, and Asia Pacific, PROACTIS also has an extensive global partner network.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKRNROUAWRAR
Date   Source Headline
29th Apr 20217:00 amRNSInterim Results
23rd Mar 20217:00 amRNSContract Win
24th Feb 20217:01 amRNSTrading Update & Notice of Results
24th Feb 20217:00 amRNSbePayd Strategic Contract Win
10th Feb 20217:00 amRNSStrategic Contract Win
8th Jan 202111:15 amRNSHolding(s) in Company
17th Dec 20208:58 amRNSDirector/PDMR Shareholding
14th Dec 20205:19 pmRNSResult of AGM
9th Dec 20207:00 amRNSFirst bePayd contract
7th Dec 20205:00 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSNotice of AGM
2nd Dec 20207:00 amRNSDirectorate Change
30th Nov 20207:00 amRNSStrategic Contract Win
19th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20205:21 pmRNSHolding(s) in Company
3rd Nov 20205:09 pmRNSHolding(s) in Company
29th Oct 202011:40 amRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSFinal Results
19th Oct 20207:00 amRNSStrategic Contract Win
14th Oct 20207:00 amRNSNotice of Results
6th Oct 20205:02 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSDirectorate Change
2nd Sep 20205:07 pmRNSHolding(s) in Company
25th Aug 20207:00 amRNSTrading Update
13th Jul 20205:04 pmRNSHolding(s) in Company
24th Jun 20207:00 amRNSHolding(s) in Company
16th Jun 20206:16 pmRNSHolding(s) in Company
28th May 20208:27 amRNSHolding(s) in Company
27th May 20205:09 pmRNSHolding(s) in Company
22nd May 20207:00 amRNSPerformance Update
21st May 202011:50 amRNSHolding(s) in Company
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSHolding(s) in Company
6th May 20205:53 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 20203:42 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:35 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSInterim Results
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 20209:05 amRNSSecond Price Monitoring Extn
28th Apr 20209:00 amRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSReset of bank facilities
20th Apr 20207:00 amRNSCOVID-19 Update & Notice of Results
8th Apr 202010:57 amRNSHolding(s) in Company
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.